{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T04:16:43Z","timestamp":1770351403495,"version":"3.49.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.lfs.2021.120182","type":"journal-article","created":{"date-parts":[[2021,11,27]],"date-time":"2021-11-27T01:35:34Z","timestamp":1637976934000},"page":"120182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Blocking I Ag7 class II major histocompatibility complex by drug-like small molecules alleviated Sj\u00f6gren's syndrome in NOD mice"],"prefix":"10.1016","volume":"288","author":[{"given":"Shivai","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danmeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Ostrov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuong Q.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lfs.2021.120182_bb0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/art.23177","article-title":"Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I","volume":"58","author":"Helmick","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.lfs.2021.120182_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coms.2013.09.002","article-title":"Sj\u00f6gren's syndrome: an update on epidemiology and current insights on pathophysiology","volume":"26","author":"Reksten","year":"2014","journal-title":"Oral Maxillofac. Surg. Clin. North Am."},{"issue":"8","key":"10.1016\/j.lfs.2021.120182_bb0015","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.3899\/jrheum.141475","article-title":"Quality of sexual life in women with primary Sj\u00f6gren syndrome","volume":"42","author":"Priori","year":"2015","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.lfs.2021.120182_bb0020","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00455-015-9657-7","article-title":"Swallowing disorders in Sj\u00f6gren's syndrome: prevalence, risk factors, and effects on quality of life","volume":"31","author":"Pierce","year":"2016","journal-title":"Dysphagia"},{"issue":"1","key":"10.1016\/j.lfs.2021.120182_bb0025","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ophtha.2014.07.026","article-title":"Ocular and systemic morbidity in a longitudinal cohort of Sj\u00f6gren's syndrome","volume":"122","author":"Akpek","year":"2015","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.lfs.2021.120182_bb0030","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s40266-013-0050-7","article-title":"Sjogren's syndrome in older patients: aetiology, diagnosis and management","volume":"30","author":"Moerman","year":"2013","journal-title":"Drugs Aging"},{"issue":"8","key":"10.1016\/j.lfs.2021.120182_bb0035","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1182\/blood-2007-10-119974","article-title":"Autoimmune disorders and risk of non-hodgkin lymphoma subtypes: a pooled analysis within the InterLymph consortium","volume":"111","author":"Ekstrom Smedby","year":"2008","journal-title":"Blood"},{"issue":"9482","key":"10.1016\/j.lfs.2021.120182_bb0040","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","article-title":"Sjogren's syndrome","volume":"366","author":"Fox","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2021.120182_bb0045","article-title":"Beyond the glands: an in-depth perspective of neurological manifestations in Sj\u00f6gren's syndrome","volume":"2014","author":"Voigt","year":"2014","journal-title":"Rheumatology (Sunnyvale)"},{"issue":"9","key":"10.1016\/j.lfs.2021.120182_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9093057","article-title":"Contributions of major cell populations to Sj\u00f6gren's syndrome","volume":"9","author":"Witas","year":"2020","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.lfs.2021.120182_bb0055","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.4049\/jimmunol.181.4.2898","article-title":"Identification of IL-18 and Th17 cells in salivary glands of patients with Sjogren's syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18","volume":"181","author":"Sakai","year":"2008","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.lfs.2021.120182_bb0060","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1242\/bio.013771","article-title":"Sexual dimorphism in an animal model of Sj\u00f6gren's syndrome: a potential role for Th17 cells","volume":"4","author":"Voigt","year":"2015","journal-title":"Biol. Open"},{"issue":"3","key":"10.1016\/j.lfs.2021.120182_bb0065","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.2353\/ajpath.2009.090319","article-title":"Systemic and local interleukin-17 and linked cytokines associated with Sj\u00f6gren's syndrome immunopathogenesis","volume":"175","author":"Katsifis","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2021.120182_bb0070","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaut.2013.11.001","article-title":"A comprehensive review of autoantibodies in primary Sjogren's syndrome: clinical phenotypes and regulatory mechanisms","volume":"51","author":"Kyriakidis","year":"2014","journal-title":"J. Autoimmun."},{"issue":"3","key":"10.1016\/j.lfs.2021.120182_bb0075","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3109\/s10165-012-0785-8","article-title":"The crucial roles of IFN-\u03b3 in the development of M3 muscarinic acetylcholine receptor induced Sj\u00f6gren's syndrome-like sialadenitis","volume":"23","author":"Iizuka","year":"2013","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.lfs.2021.120182_bb0080","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.clim.2018.04.009","article-title":"Unique glandular ex-vivo Th1 and Th17 receptor motifs in Sjogren's syndrome patients using single-cell analysis","volume":"192","author":"Voigt","year":"2018","journal-title":"Clin. Immunol."},{"issue":"3","key":"10.1016\/j.lfs.2021.120182_bb0085","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/art.23214","article-title":"Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sj\u00f6gren's syndrome: findings in humans and mice","volume":"58","author":"Nguyen","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.lfs.2021.120182_bb0090","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/annrheumdis-2013-204584","article-title":"Th17 cells play a critical role in the development of experimental Sj\u00f6gren's syndrome","volume":"74","author":"Lin","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.lfs.2021.120182_bb0095","doi-asserted-by":"crossref","first-page":"12512","DOI":"10.1038\/s41598-017-12627-6","article-title":"Single-cell analysis reveals sexually dimorphic repertoires of interferon-\u03b3 and IL-17A producing T cells in salivary glands of Sj\u00f6gren\u2019s syndrome mice","volume":"7","author":"Wanchoo","year":"2017","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.lfs.2021.120182_bb0100","doi-asserted-by":"crossref","first-page":"R220","DOI":"10.1186\/ar3207","article-title":"Pathogenic effect of interleukin-17A in induction of Sj\u00f6gren's syndrome-like disease using adenovirus-mediated gene transfer","volume":"12","author":"Nguyen","year":"2010","journal-title":"Arthritis Res. Ther."},{"issue":"11","key":"10.1016\/j.lfs.2021.120182_bb0105","doi-asserted-by":"crossref","first-page":"5921","DOI":"10.4049\/jimmunol.1100746","article-title":"Structure-based selection of small molecules to alter allele-specific MHC class II antigen presentation","volume":"187","author":"Michels","year":"2011","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.lfs.2021.120182_bb0110","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1172\/JCI97739","article-title":"Methyldopa blocks MHC class II binding to disease-specific antigens in autoimmune diabetes","volume":"128","author":"Ostrov","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2021.120182_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102402","article-title":"Cepharanthine blocks TSH receptor peptide presentation by HLA-DR3: therapeutic implications to Graves' disease","volume":"108","author":"Li","year":"2020","journal-title":"J. Autoimmun."},{"issue":"8","key":"10.1016\/j.lfs.2021.120182_bb0120","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1074\/jbc.M115.694687","article-title":"Identifying a small molecule blocking antigen presentation in autoimmune thyroiditis","volume":"291","author":"Li","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.lfs.2021.120182_bb0125","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.autrev.2011.10.002","article-title":"HLA and Sjogren's syndrome susceptibility. A meta-analysis of worldwide studies","volume":"11","author":"Cruz-Tapias","year":"2012","journal-title":"Autoimmun. Rev."},{"issue":"11","key":"10.1016\/j.lfs.2021.120182_bb0130","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/ng.2792","article-title":"Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjogren's syndrome","volume":"45","author":"Lessard","year":"2013","journal-title":"Nat. Genet."},{"issue":"4754","key":"10.1016\/j.lfs.2021.120182_bb0135","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.3458307","article-title":"Gene interaction at HLA-DQ enhances autoantibody production in primary Sjogren's syndrome","volume":"232","author":"Harley","year":"1986","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.lfs.2021.120182_bb0140","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1002\/art.11103","article-title":"In primary Sjogren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response","volume":"48","author":"Gottenberg","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.lfs.2021.120182_bb0145","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.3899\/jrheum.080234","article-title":"Association of severe inflammatory polyarthritis in primary Sjogren's syndrome: clinical, serologic, and HLA analysis","volume":"36","author":"Mohammed","year":"2009","journal-title":"J. Rheumatol."},{"issue":"Pt 4","key":"10.1016\/j.lfs.2021.120182_bb0150","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"issue":"Pt 10","key":"10.1016\/j.lfs.2021.120182_bb0155","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1107\/S2059798319011471","article-title":"Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in phenix","volume":"75","author":"Liebschner","year":"2019","journal-title":"Acta Crystallogr. D Struct. Biol."},{"issue":"16","key":"10.1016\/j.lfs.2021.120182_bb0160","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"issue":"2","key":"10.1016\/j.lfs.2021.120182_bb0165","doi-asserted-by":"crossref","DOI":"10.1186\/ar2676","article-title":"Differential gene expression in the salivary gland during development and onset of xerostomia in Sjogren's syndrome-like disease of the C57BL\/6.NOD-Aec1Aec2 mouse","volume":"11","author":"Nguyen","year":"2009","journal-title":"Arthritis Res. Ther."},{"issue":"7","key":"10.1016\/j.lfs.2021.120182_bb0170","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.4049\/jimmunol.168.7.3635","article-title":"Human DQ8 can substitute for murine I-Ag7 in the selection of diabetogenic T cells restricted to I-Ag7","volume":"168","author":"Wen","year":"2002","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.lfs.2021.120182_bb0175","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1084\/jem.185.6.1013","article-title":"A peptide-binding motif for I-A(g7), the class II major histocompatibility complex (MHC) molecule of NOD and Biozzi AB\/H mice","volume":"185","author":"Harrison","year":"1997","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.lfs.2021.120182_bb0180","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/art.1780190508","article-title":"Association of Sj\u00f6gren's syndrome with HLA-B8","volume":"19","author":"Fye","year":"1976","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.lfs.2021.120182_bb0185","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/549107","article-title":"Current concepts: mouse models of Sj\u00f6gren's syndrome","volume":"2011","author":"Lavoie","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"issue":"18","key":"10.1016\/j.lfs.2021.120182_bb0190","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.2174\/1381612821666150316120024","article-title":"Mouse models of primary Sjogren's syndrome","volume":"21","author":"Park","year":"2015","journal-title":"Curr. Pharm. Des."},{"issue":"4","key":"10.1016\/j.lfs.2021.120182_bb0195","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/08916930410001708715","article-title":"Sjogren's syndrome","volume":"37","author":"Soliotis","year":"2004","journal-title":"Autoimmunity"},{"issue":"5","key":"10.1016\/j.lfs.2021.120182_bb0200","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1093\/rheumatology\/kez142","article-title":"Treatment of Sj\u00f6gren's syndrome: current therapy and future directions","volume":"60","author":"Fox","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.lfs.2021.120182_bb0205","first-page":"e584","article-title":"Sjogren's syndrome: review of the aetiology, pathophysiology & potential therapeutic interventions","volume":"9","author":"Nair","year":"2017","journal-title":"J Clin Exp Dent"},{"issue":"3","key":"10.1016\/j.lfs.2021.120182_bb0210","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.4049\/jimmunol.168.3.1235","article-title":"In APCs, the autologous peptides selected by the diabetogenic I-Ag7 molecule are unique and determined by the amino acid changes in the P9 pocket","volume":"168","author":"Suri","year":"2002","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.lfs.2021.120182_bb0215","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.4049\/jimmunol.154.10.5567","article-title":"Aspartate at position 57 of nonobese diabetic I-Ag7 beta-chain diminishes the spontaneous incidence of insulin-dependent diabetes mellitus","volume":"154","author":"Quartey-Papafio","year":"1995","journal-title":"J. Immunol."},{"issue":"6345","key":"10.1016\/j.lfs.2021.120182_bb0220","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/353622a0","article-title":"Sequence analysis of peptides bound to MHC class II molecules","volume":"353","author":"Rudensky","year":"1991","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.lfs.2021.120182_bb0225","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1365-2567.2012.03579.x","article-title":"Characterizing the binding motifs of 11 common human HLA-DP and HLA-DQ molecules using NNAlign","volume":"136","author":"Andreatta","year":"2012","journal-title":"Immunology"},{"issue":"6389","key":"10.1016\/j.lfs.2021.120182_bb0230","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/358764a0","article-title":"Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size","volume":"358","author":"Chicz","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2021.120182_bb0235","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1745-7580-4-6","article-title":"Peptide length significantly influences in vitro affinity for MHC class II molecules","volume":"4","author":"O'Brien","year":"2008","journal-title":"Immunome Res."},{"key":"10.1016\/j.lfs.2021.120182_bb0240","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/ncomms1665","article-title":"Modification of the carboxy-terminal flanking region of a universal influenza epitope alters CD4+ T-cell repertoire selection","volume":"3","author":"Cole","year":"2012","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.lfs.2021.120182_bb0245","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1002\/1521-4141(200209)32:9<2510::AID-IMMU2510>3.0.CO;2-Q","article-title":"Recognition of core and flanking amino acids of MHC class II-bound peptides by the T cell receptor","volume":"32","author":"Sant'Angelo","year":"2002","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.lfs.2021.120182_bb0250","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1084\/jem.189.3.531","article-title":"Immune responses to Ro60 and its peptides in mice. I. The nature of the immunogen and endogenous autoantigen determine the specificities of the induced autoantibodies","volume":"189","author":"Deshmukh","year":"1999","journal-title":"J. Exp. Med."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2021.120182_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2014.02.004","article-title":"T cell epitope mimicry between Sj\u00f6gren's syndrome Antigen A (SSA)\/Ro60 and oral, gut, skin and vaginal bacteria","volume":"152","author":"Szymula","year":"2014","journal-title":"Clin. Immunol."},{"issue":"3","key":"10.1016\/j.lfs.2021.120182_bb0260","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.2353\/ajpath.2009.081058","article-title":"Sjogren's syndrome-like ocular surface disease in thrombospondin-1 deficient mice","volume":"175","author":"Turpie","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2021.120182_bb0265","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/826191","article-title":"Design of peptide immunotherapies for MHC Class-II-associated autoimmune disorders","volume":"2013","author":"Fridkis-Hareli","year":"2013","journal-title":"Clin. Dev. Immunol."},{"issue":"20","key":"10.1016\/j.lfs.2021.120182_bb0270","first-page":"354","article-title":"The diagnosis and treatment of Sj\u00f6gren's Syndrome","volume":"114","author":"Stefanski","year":"2017","journal-title":"Dtsch. Arztebl. Int."},{"issue":"3","key":"10.1016\/j.lfs.2021.120182_bb0275","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.rdc.2016.03.010","article-title":"New treatment guidelines for Sj\u00f6gren's disease","volume":"42","author":"Vivino","year":"2016","journal-title":"Rheum. Dis. Clin. N. Am."},{"issue":"7","key":"10.1016\/j.lfs.2021.120182_bb0280","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/rheumatology\/keu004","article-title":"Rituximab modulates IL-17 expression in the salivary glands of patients with primary Sj\u00f6gren's syndrome","volume":"53","author":"Ciccia","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.lfs.2021.120182_bb0285","first-page":"555","article-title":"Methotrexate in primary Sj\u00f6gren's syndrome","volume":"14","author":"Skopouli","year":"1996","journal-title":"Clin. Exp. Rheumatol."},{"issue":"3","key":"10.1016\/j.lfs.2021.120182_bb0290","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.2014.7682","article-title":"Effects of hydroxychloroquine on symptomatic improvement in primary Sj\u00f6gren syndrome: the JOQUER randomized clinical trial","volume":"312","author":"Gottenberg","year":"2014","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.lfs.2021.120182_bb0295","first-page":"896","article-title":"A double blind placebo controlled trial of azathioprine in the treatment of primary Sj\u00f6gren's syndrome","volume":"25","author":"Price","year":"1998","journal-title":"J. Rheumatol."},{"issue":"7","key":"10.1016\/j.lfs.2021.120182_bb0300","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1093\/rheumatology\/kez004","article-title":"T cells in primary Sj\u00f6gren's syndrome: targets for early intervention","volume":"60","author":"Verstappen","year":"2019","journal-title":"Rheumatology (Oxford)"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521011693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521011693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T10:32:57Z","timestamp":1717237977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320521011693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":60,"alternative-id":["S0024320521011693"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2021.120182","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blocking IAg7 class II major histocompatibility complex by drug-like small molecules alleviated Sj\u00f6gren's syndrome in NOD mice","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2021.120182","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"120182"}}